Last reviewed · How we verify

NCT04313413

Yoga@Work for Reducing Musculoskeletal Pain in Neck and Shoulder

Completed NA Last updated 20 March 2020
What this trial tests

NA trial testing Yoga in Neck Pain in 34 participants. Completed in 18 July 2019.

Timeline
12 January 2019
Primary endpoint
18 June 2019
18 July 2019

Quick facts

Lead sponsorAarogyam UK
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment34
Start date12 January 2019
Primary completion18 June 2019
Estimated completion18 July 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Aarogyam UK — full company profile →

Who can join

Adults 18 to 18, any sex, with Neck Pain or Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Work-related musculoskeletal disorders (MSDs) are disorders of muscles, tendons, joints and nerves which can affect all body parts, although the neck, upper limb and back are the most common areas. The peer-reviewed literature about workplace prevention describes a variety of interventions that have been implemented and evaluated.but only few studies show sustainable positive effects on symptom outcomes. Yoga@Work program was developed to self manage pain around neck and shoulder areas among office workers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other Aarogyam UK trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04313413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing